Pomalidomide Active Not Recruiting Phase 1 Trials for Relapsed Or Refractory Multiple Myeloma Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02939183Phase 1b Study Evaluating OPomD in Relapsed or Refractory Multiple Myeloma